Thomas S. Hayday - Concepedia

Concepedia

Author

Thomas S. Hayday

King's College London ORCID

Also Known As

Thomas Hayday, Thomas S Hayday, Thomas S. Hayday

20

Publications

2.2K

Citations

13

H-Index

40

Concepts

All Affiliations

King's College London University College London Guy's and St Thomas' NHS Foundation Trust The Francis Crick Institute Royal Free London NHS Foundation Trust

TS

About

Thomas S. Hayday is an author at King's College London specializing in medicine, immunology, and humoral immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	287
2	Immunology	4	4	274
3	Cell Biology	2	2	60
4	Natural Sciences	1	1	13
5	Cellular Physiology	1	1	13

Thomas S. Hayday

×

13

Publications

2.2K

Citations

13

H-Index

	Year	Citations
A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Nature Medicine	2020	1K
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, The Lancet Oncology	2021	608
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, Cancer Cell Their LegaciesViral PersistenceViral DiagnosticsRespiratory DiseasesImmunology	2021	114
Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate Jack Bibby, Harriet A. Purvis, Thomas S. Hayday, Nature Communications	2020	85
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Nature Medicine	2020	67
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, ImmunologyCancer PatientsVaccine HesitancyImmunotherapyCovid-19	2021	60
A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Adaptive Immune SystemHumoral ResponseImmunologyImmunodominanceImmunologic Mechanism	2020	53
Acquisition of MHC:Peptide Complexes by Dendritic Cells Contributes to the Generation of Antiviral CD8+ T Cell Immunity In Vivo Lesley A. Smyth, Catherine Hervouet, Thomas S. Hayday, The Journal of Immunology Adaptive Immune SystemVirus-infected DcsImmunologyImmunodominanceImmunologic Mechanism	2012	47
Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2 James L. Reading, Bart Vaes, Caroline Hull, Molecular Therapy	2015	43
Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23 John Y.W. Lee, Chao‐Kai Hsu, Magdalene Michael, The American Journal of Human Genetics	2017	34

Page 1